Source: International Congress 2017 – Airway disease and exacerbations
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Lázár (Budapest, Hungary). Acinar and bronchial nitric oxide levels in stable and exacerbated COPD.. 1118

Member's Comments

No comment yet.

Related content which might interest you: Features of production nitric oxide at patients with a bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006 Changes in nitric oxide production in patients with bronchial asthma Source: Eur Respir J 2007; 30: Suppl. 51, 588s Year: 2007 Increased nitric oxide production by neutrophils in bronchial asthma Source: Eur Respir J 2001; 17: 868-871 Year: 2001 Hyperinflation is associated with reduced nitric oxide production in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 226s Year: 2005 Serum nitric oxide metabolists in bronchial asthma patients Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond Year: 2008 Exhaled nitric oxide in stable adult cystic fibrosis patients, during exacerbation and following CFTR-modifying treatment Source: Eur Respir J, 53 (5) 1802259; 10.1183/13993003.02259-2018 Year: 2019 Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Inhaled salbutamol significantly affects the bronchial production of nitric oxide in normal subjects Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement Year: 2008 Fractional exhaled nitric oxide for eosinophilic inflammation in stable COPD Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms Source: Eur Respir J 2002; 20: 841-845 Year: 2002 Increased bronchial but not alveolar exhaled nitric oxide is associated with snoring Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 Alveolar nitric oxide is increased in uncontrolled asthma Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010 Airway and systemic nitric oxide pathway in COPD Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Comparisons for concentration in exhaled nitric oxide between patients with bronchial asthma and COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Changes in nitric oxide production in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 190s Year: 2006 Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma Source: Eur Respir J 2008; 32: 344-349 Year: 2008 Salbutamol temporarily increases the bronchial production of nitric oxide Source: Eur Respir J 2007; 30: Suppl. 51, 63s Year: 2007 Nasal nitric oxide Source: Eur Respir Monogr 2010; 49: 71-81 Year: 2010 The nitric oxide (NO) metabolites in monitoring and therapy of bronchial asthma Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011